Financial Data and Key Metrics Changes - Revenue for Q2 2025 was $139.6 million, a 3% increase year-over-year and a 5% increase sequentially, driven by strong demand in aerospace, defense, industrial markets, and select medical applications [9][10] - Gross margin reached a record 33.2%, up 100 basis points sequentially and 330 basis points year-over-year, attributed to a favorable mix, higher volumes, and improved operating discipline [6][13] - Net income increased to $5.6 million or $0.34 per diluted share, with adjusted net income at $9.5 million or $0.57 per diluted share, up from $0.46 in Q1 and $0.29 in the prior year [14][15] - Operating cash flow was a record $24.5 million, up 76% sequentially and nearly three times the level from the same period last year [17][18] Business Line Data and Key Metrics Changes - Aerospace and defense revenue grew 13%, reflecting strong execution and program timing [10] - Medical revenue increased by 4%, driven by solid demand for surgical instruments [11] - Industrial market revenue rose by 3%, supported by strength in HVAC and data center applications [11] - Vehicle revenue decreased by 7% due to ongoing softness in powersports, although there was sequential improvement [11][12] Market Data and Key Metrics Changes - Sales to U.S. customers accounted for 55% of total revenue, consistent with the previous year [9] - The backlog at the end of the quarter was $236.6 million, slightly down from Q1 and prior year levels, as customers managed through inventory normalization [21] - Demand trends in key sectors like industrial and aerospace and defense remain steady, with signs of recovery in industrial automation [21][23] Company Strategy and Development Direction - The company is focused on sustainable, profitable growth while delivering value to customers, employees, and shareholders [22] - The "Simplify to Accelerate Now" program is central to performance, driving efficiency and responsiveness across global operations [6][23] - The company is proactively managing external risks, including tariffs and supply dynamics related to rare earth materials [23] Management's Comments on Operating Environment and Future Outlook - Management noted that the destocking cycle appears to be largely behind them, with order activity becoming more consistent [21] - There is cautious optimism regarding the recovery in industrial automation and steady momentum in aerospace and defense [23] - The company expects Q3 sales to be sequentially lower due to revenue pulled into Q2, but remains confident in long-term growth prospects [22] Other Important Information - The company reduced debt by $20 million during the quarter, bringing net debt down by $35.8 million year-to-date [19] - Capital expenditures for the first half of the year were $3.2 million, with a revised full-year outlook of $8 million to $10 million [19] Q&A Session Summary Question: Insights on destocking and industrial demand - Management confirmed that destocking appears to be in the rearview mirror, with positive signs in industrial demand [29] Question: Aerospace and defense exposure and demand visibility - Management highlighted strong long-term visibility in aerospace and defense, with ongoing improvements in operating capabilities [30][31] Question: Rare earth magnets risk profile - Management expressed cautious optimism regarding supply chain improvements but acknowledged ongoing risks related to sourcing from China [34][35] Question: Revenue pull forward sources - The majority of revenue pull forward came from medical, high-end industrial, and defense segments [46][48] Question: Capacity for data center demand - Management confirmed that they are increasing capacity to meet growing demand in the data center market [82] Question: Automation market recovery - Management noted signs of normalization in the automation market, expecting positive impacts moving forward [85][86] Question: Munitions business capacity constraints - Management stated that they are not capacity constrained in the munitions business and have seen increased orders [90][91]